{"id":276771,"date":"2026-09-29T10:55:00","date_gmt":"2026-09-29T05:25:00","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=276771"},"modified":"2026-09-29T10:55:00","modified_gmt":"2026-09-29T05:25:00","slug":"why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/","title":{"rendered":"Syncom Formulations (India) Ltd. (SYNCOMF): Syncom Formulations (India) Share Price rises 9.01% today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/syncomf\/syncom-formulations-india-ltd-share-price-today\">Syncom Formulations (India) Ltd. (SYNCOMF)<\/a> share price rose to Rs 24.2 today, up 9.01% from the previous close. Market cap was Rs 1,885.64 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 29 September 2026 at 10:52:43 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Syncom Formulations (India) Share Price moved higher today, with the stock at Rs 24.20 after a 9.01% rise from the previous close of Rs 22.20. The company\u2019s market capitalisation stands at Rs 1,885.64 crore, placing the latest move in the context of a company that is already meaningfully valued within the healthcare space. The session opened at Rs 22.36, touched a high of Rs 24.85 and a low of Rs 22.06, while turnover stood at Rs 8.11 crore. This <strong>Syncom Formulations (India) Share Price<\/strong> update confirms a clear same-day gain, but the supplied data does not establish a company-specific catalyst. For readers following <strong>Syncom Formulations (India) Stock News<\/strong> or <strong>Syncom Formulations (India) Share Price Today<\/strong>, the key point is the magnitude of the day move and the company\u2019s valuation backdrop. Univest is tracking the stock with a focus on verified price data, financial ratios and sector context.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#Syncom_Formulations_India_Share_Price_Today_Price_Action_Analysis\" title=\"Syncom Formulations (India) Share Price Today: Price Action Analysis\">Syncom Formulations (India) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#Syncom_Formulations_India_Ltd_SYNCOMF_Fundamental_Analysis\" title=\"Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis\">Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#Why_Investors_Are_Watching_Syncom_Formulations_India\" title=\"Why Investors Are Watching Syncom Formulations (India)\">Why Investors Are Watching Syncom Formulations (India)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#About_Syncom_Formulations_India\" title=\"About Syncom Formulations (India)\">About Syncom Formulations (India)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#Track_Syncom_Formulations_India_Share_Price_on_Univest\" title=\"Track Syncom Formulations (India) Share Price on Univest\">Track Syncom Formulations (India) Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#Why_did_Syncom_Formulations_India_Share_Price_rise_today\" title=\"Why did Syncom Formulations (India) Share Price rise today?\">Why did Syncom Formulations (India) Share Price rise today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#What_is_Syncom_Formulations_India_Share_Price_today\" title=\"What is Syncom Formulations (India) Share Price today?\">What is Syncom Formulations (India) Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#How_much_did_Syncom_Formulations_India_share_price_gain_today\" title=\"How much did Syncom Formulations (India) share price gain today?\">How much did Syncom Formulations (India) share price gain today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#What_is_the_market_capitalisation_of_Syncom_Formulations_India\" title=\"What is the market capitalisation of Syncom Formulations (India)?\">What is the market capitalisation of Syncom Formulations (India)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#How_does_Syncom_Formulations_India_look_on_valuation\" title=\"How does Syncom Formulations (India) look on valuation?\">How does Syncom Formulations (India) look on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#What_do_Syncom_Formulations_India_ROE_and_ROCE_show\" title=\"What do Syncom Formulations (India) ROE and ROCE show?\">What do Syncom Formulations (India) ROE and ROCE show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#How_does_Syncom_Formulations_India_compare_with_peers\" title=\"How does Syncom Formulations (India) compare with peers?\">How does Syncom Formulations (India) compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-price-rise-2026-09-29\/#Can_investors_track_Syncom_Formulations_India_Share_Price_on_Univest\" title=\"Can investors track Syncom Formulations (India) Share Price on Univest?\">Can investors track Syncom Formulations (India) Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_India_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Syncom Formulations (India) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 24.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2 (+9.01%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 24.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 8.11 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,885.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Small Cap<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) rose to Rs 24.2 from the previous close of Rs 22.2, a move of Rs 2 or 9.01%. The stock opened at Rs 22.36, reached a high of Rs 24.85, recorded a low of Rs 22.06.<\/p>\n<p>Syncom Formulations (India) Share Price rose Rs 2.00 on the day, closing at Rs 24.20 versus the previous close of Rs 22.20. The stock traded between Rs 22.06 and Rs 24.85 during the session, with the opening price at Rs 22.36. The day\u2019s move places the counter among the notable gainers in the healthcare space today, and the current reading of <strong>Syncom Formulations (India) Share Price Today<\/strong> shows a stronger finish than the previous close. The latest <strong>Syncom Formulations (India) Stock News<\/strong> therefore centres on the verified price rise and the session range, rather than on any unconfirmed trigger. Turnover of Rs 8.11 crore provides a factual measure of traded value for the session.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_India_Ltd_SYNCOMF_Fundamental_Analysis\"><\/span><strong>Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,885.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.91<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.45%<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P\/E 24.4x, P\/B 4.74x, ROE 20.19%, ROCE 26.8%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Syncom Formulations (India) Ltd. has a market capitalisation of Rs 1885.64 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 24.4x, P\/B at 4.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.19% and ROCE of 26.8%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0.45%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.59x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.46x to 707.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,885.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 783.26 crore<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a P\/E ratio of 24.4x, which is below the benchmark median of 32.59x, a difference of -25.13%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 20.19%, which is above the benchmark median of 11.7%, a difference of +72.56%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 26.8%, which is above the benchmark median of 13.61%, a difference of +96.91%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,55,115.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,613.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,19,899.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,875.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a P\/E ratio of 24.4x compared with the displayed peer median of 36.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.19% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.8% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 1,885.64 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Syncom_Formulations_India\"><\/span><strong>Why Investors Are Watching Syncom Formulations (India)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>The <strong>Syncom Formulations (India) Share Price<\/strong> rose 9.01% today to Rs 24.20.<\/li>\n<li>The session range was Rs 22.06 to Rs 24.85, with an opening price of Rs 22.36.<\/li>\n<li>Market capitalisation stands at Rs 1,885.64 crore, which frames the current <strong>Syncom Formulations (India) Stock News<\/strong>.<\/li>\n<li>ROE is 20.19% and ROCE is 26.8%, both above the sector median for the industry.<\/li>\n<li>P\/E of 24.4 and P\/B of 4.74 place the stock within a clear valuation comparison set in Healthcare.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Syncom_Formulations_India\"><\/span><strong>About Syncom Formulations (India)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Syncom Formulations (India) is part of the Healthcare sector and operates in Pharmaceuticals &amp; Drugs. The company\u2019s share price update is being discussed in the context of a listed pharmaceutical business whose market capitalisation, valuation ratios and profitability metrics are now available for comparison on Univest. Based on the supplied data, the stock belongs to an industry where valuations and return ratios vary widely across peers, and that makes company-specific fundamentals important for reading the day\u2019s move. The latest <strong>Syncom Formulations (India) Share News<\/strong> therefore sits at the intersection of price action, profitability and industry benchmarking. Readers tracking <strong>Syncom Formulations (India) Latest News<\/strong> can use this context to understand the stock\u2019s position within the broader healthcare market.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Syncom_Formulations_India_Share_Price_on_Univest\"><\/span><strong>Track Syncom Formulations (India) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/syncomf\/syncom-formulations-india-ltd-share-price-today\">Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Syncom_Formulations_India_Share_Price_rise_today\"><\/span><strong>Why did Syncom Formulations (India) Share Price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms a 9.01% rise in Syncom Formulations (India) Share Price to Rs 24.20, but it does not establish a company-specific catalyst. The article therefore focuses on verified price action, turnover and valuation context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Syncom_Formulations_India_Share_Price_today\"><\/span><strong>What is Syncom Formulations (India) Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations (India) Share Price today is Rs 24.20, compared with the previous close of Rs 22.20. The stock added Rs 2.00 during the session and moved within a range of Rs 22.06 to Rs 24.85.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Syncom_Formulations_India_share_price_gain_today\"><\/span><strong>How much did Syncom Formulations (India) share price gain today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations (India) share price gained 9.01% today. That move came with a Rs 2.00 increase from the previous close, and the stock finished the day at Rs 24.20. The previous close was Rs 22.2.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Syncom_Formulations_India\"><\/span><strong>What is the market capitalisation of Syncom Formulations (India)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations (India) has a market capitalisation of Rs 1,885.64 crore. This places the company above the sector median market cap in the same industry benchmark, though below the larger listed pharmaceutical names.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Syncom_Formulations_India_look_on_valuation\"><\/span><strong>How does Syncom Formulations (India) look on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations (India) has a P\/E ratio of 24.4 and a P\/B ratio of 4.74. Its P\/E is below the same-industry median, while its P\/B is above the median and close to the sector average.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Syncom_Formulations_India_ROE_and_ROCE_show\"><\/span><strong>What do Syncom Formulations (India) ROE and ROCE show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE is 20.19% and ROCE is 26.8% for Syncom Formulations (India). Both are above the same-industry median and average, which gives useful profitability context alongside the day\u2019s share price rise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Syncom_Formulations_India_compare_with_peers\"><\/span><strong>How does Syncom Formulations (India) compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Its ROCE is higher than most shown peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_investors_track_Syncom_Formulations_India_Share_Price_on_Univest\"><\/span><strong>Can investors track Syncom Formulations (India) Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Univest tracks Syncom Formulations (India) Share Price with live updates, valuation ratios, company fundamentals, sector comparisons and market-cap context. Readers can use it to follow the stock\u2019s verified movements and financial profile.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Syncom Formulations (India) Ltd. Share Price rises to Rs 24.2. marking a 9.01% rise today. Market cap stands at Rs 1,885.64 crore.<\/p>\n","protected":false},"author":29,"featured_media":276769,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-276771","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["276769"],"rank_math_title":["Syncom Formulations Share Price rise: valuation and peers"],"rank_math_description":["Syncom Formulations Share Price rose 9.01% to Rs 24.20. Read today's move, market cap, fundamentals, sector benchmark and peer comparison."],"rank_math_focus_keyword":["Syncom Formulations (India) Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/syncom-formulations-india-ltd-syncomf-syncom-formulations-india-share-price.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/276771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=276771"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/276771\/revisions"}],"predecessor-version":[{"id":276772,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/276771\/revisions\/276772"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/276769"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=276771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=276771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=276771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}